Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Federal Trade Commission
Chubb
Deloitte
Citi

Generated: April 20, 2019

DrugPatentWatch Database Preview

FINASTERIDE Drug Profile

« Back to Dashboard

Which patents cover Finasteride, and what generic alternatives are available?

Finasteride is a drug marketed by Accord Hlthcare, Actavis Totowa, Actavis Totowa Teva, Alkem Labs Ltd, Aurobindo Pharma, Aurobindo Pharma Ltd, Cipla, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Gedeon Richter Usa, Hetero Labs Ltd Iii, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Sun Pharma Global, Teva, and Zydus Pharms Usa Inc. and is included in twenty-two NDAs.

The generic ingredient in FINASTERIDE is finasteride. There are fourteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the finasteride profile page.

Drug patent expirations by year for FINASTERIDE
Pharmacology for FINASTERIDE
Medical Subject Heading (MeSH) Categories for FINASTERIDE
Synonyms for FINASTERIDE
(17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one
(1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-3-ene-14-carboxamide
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
(4AR,4BS,6AS,7S,9AS,9BS,11AR)-4A,6A-DIMETHYL-2-OXO-2,4A,4B,5,6,6A,7,8,9,9A,9B,10,11,11A-TETRADECAHYDRO-1H-INDENO[5,4-F]QUINOLINE-7-CARBOXYLIC ACID TERT-BUTYLAMIDE
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-dimethylethyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-Butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,1
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
(4aR,4bS,6aS,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
(4aR,6aS,11aR)-4a,6a-Dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
(4aR,6aS,7S,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
(4aR,6aS,7S)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
(4aR,6aS)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
(R)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
17beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androst-1-en-3-one
319F267
32329-EP2272827A1
32329-EP2275420A1
32329-EP2280012A2
32329-EP2281815A1
32329-EP2292615A1
32329-EP2295055A2
32329-EP2295416A2
32329-EP2295426A1
32329-EP2295427A1
32329-EP2298748A2
32329-EP2298764A1
32329-EP2298765A1
32329-EP2298768A1
32329-EP2301928A1
32329-EP2301933A1
32329-EP2305640A2
32329-EP2305642A2
32329-EP2305671A1
32329-EP2311453A1
32329-EP2311808A1
32329-EP2311825A1
32329-EP2311827A1
32329-EP2311829A1
32329-EP2311840A1
4-azaandrost-1-ene-17-carboxamide, N -(1,1-dimethylethyl)-3-oxo-,(5(alpha),17(beta))-
4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha, 17beta)-
4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)-
4-Azaandrost-1-ene-17-carboxamide,1-dimethylethyl)-3-oxo-, (5.alpha., 17.beta.)-
4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide(Finasteride)
4a,6a,9a-Trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid (Finasteride)
57GNO57U7G
98319-26-7
AB00513901
AB00513901_09
AB00513901-07
AB00513901-08
AB07586
AB1008360
AC1L1MUF
AC1Q5L2C
ACT02599
AJ-45596
AK-72879
AKOS015894916
AN-615
Andozac
BC200264
BCP0726000222
BCP9000685
BCPP000229
BDBM50334788
BPBio1_001027
BR-72879
BRD-K01095011-001-03-5
BRD-K01095011-001-15-9
BRN 4269024
BSPBio_000933
C-34893
C23H36N2O2
CAS-98319-26-7
CC-28426
CCG-100937
CCRIS 7438
CHEBI:5062
CHEMBL710
Chibro-Proscar
CPD000466304
CS-1767
D00321
DB01216
DBEPLOCGEIEOCV-WSBQPABSSA-N
DSSTox_CID_625
DSSTox_GSID_20625
DSSTox_RID_75699
DTXSID3020625
EX-A1951
Finasterida
Finasterida [INN-Spanish]
Finasteride (JAN/USP/INN)
Finasteride (Proscar)
Finasteride [USAN:INN:BAN]
Finasteride [USAN:USP:INN:BAN]
Finasteride for peak identification, European Pharmacopoeia (EP) Reference Standard
Finasteride, >=98% (HPLC), powder
Finasteride, 98%
Finasteride, British Pharmacopoeia (BP) Reference Standard
Finasteride, European Pharmacopoeia (EP) Reference Standard
Finasteride, United States Pharmacopeia (USP) Reference Standard
Finasteride, VETRANAL(TM), analytical standard
Finasteridum
Finasteridum [INN-Latin]
Finastid
Finpecia
FT-0082891
GTPL6818
HMS1570O15
HMS2051F09
HMS2090G22
HMS2097O15
HMS2235L23
HMS3714O15
HSDB 6793
HY-13635
J10122
KS-1058
L-652,931
LS-7397
MFCD00869737
MK 0906
MK 906
MK-0906
MK-906
MK906
MLS000759404
MLS001165768
MLS001424046
MolPort-002-500-272
N-(2-Methyl-2-propyl)-3-oxo-4-aza-5-alpha-androst-1-ene-17-beta-carboxamide
N-(2-methyl-2-propyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
N-tert-Butyl-3-oxo-4-aza-5|A-androst-1-en-17|A-carboxamide; N-(2-Methyl-2-propyl)-3-oxo-4-aza-5|A-androst-1-ene-17|A-carboxamide
N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide
N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
NC00187
NCGC00016965-01
NCGC00093560-05
NCGC00256334-01
NCGC00259057-01
NSC-741485
NSC741485
Prestwick0_000717
Prestwick1_000717
Prestwick2_000717
Prestwick3_000717
Propecia
Propecia (TN)
Proscar
Proscar (TN)
Prostide
s1197
SC-12178
SCHEMBL5509
SMR000466304
SPBio_002854
SR-01000759414
SR-01000759414-4
SR-01000759414-6
ST2419391
Tox21_110717
Tox21_110717_1
Tox21_201506
Tox21_302744
UNII-57GNO57U7G
X-2990
YM-152
ZINC3782599

US Patents and Regulatory Information for FINASTERIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare FINASTERIDE finasteride TABLET;ORAL 091643-001 Nov 5, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharma Global FINASTERIDE finasteride TABLET;ORAL 090508-001 Jul 1, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma FINASTERIDE finasteride TABLET;ORAL 078341-001 Oct 30, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Totowa Teva FINASTERIDE finasteride TABLET;ORAL 077914-001 Mar 28, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
QuintilesIMS
Citi
McKesson
Cantor Fitzgerald
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.